What happened
Bukwang Pharmaceutical IND updated the disclosed terms of an acquisition, now worth US$20.1M.
For context, this deal is worth about 6.3% of the company's own total assets.
| Target | Disclosed |
|---|---|
| Deal value | US$20.1M |
| vs. company assets | 6.3% |
| Filed | 2026-05-13, [Amended] Decision to acquire shares/equity in another company |
| Source | DART rcept 20260513800491 → open original filing |
Versions of this filing
- 2026-04-27Original
- 2026-05-13Amendment 1 (this page)
Source: DART. Information only, not investment advice.